| Location: | Maryland |
|---|---|
| Posted: | Feb 6, 2026 |
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Type of Contract: | Awards |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | 75N91026P00006 |
| Publication URL: | To access bid details, please log in. |
This is a Firm Fixed Price Purchase Order. The National Cancer Institute (NCI) awarded a purchase order to Ferox LLC to obtain a Bond Rx Controller for a clinical instrument (Leica Bond) Automated Immunohistochemistry stainer annual (1 year warranty included) and recommended Preventative Maintenance post-instrument relocation (with PM Kit included). The instrument will be used for validation of clinical IHC target markers for diagnostic and in some cases enrollment to NIH clinical trials. In the clinical research application, the Bond Rx instrument will be used for critical research in rare tumor identification and subsequent development of therapeutic mechanisms for patients undergoing treatments.

With GovernmentContracts, you can:
Follow PUMP UNIT, CENTRIFUGAL Active Contract Opportunity Notice ID 70Z08026P21069B00 Related Notice Department/Ind.
HOMELAND SECURITY, DEPARTMENT OF
Bid Due: 6/12/2026
Follow Legal Services for Unaccompanied Alien Children (UAC) Active Contract Opportunity Notice ID
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Bid Due: 6/15/2026
Follow Procurement of a Humanoid Robot Active Contract Opportunity Notice ID 1333ND26QNB730241 Related
COMMERCE, DEPARTMENT OF
Bid Due: 6/15/2026
Follow NOTICE OF INTENT: AgilePlace Project Management Software Active Contract Opportunity Notice ID
COMMERCE, DEPARTMENT OF
Bid Due: 6/17/2026